DrugChEMBL
Almotriptan
Total Trials
2
Max Phase
-
Type
DRUG
Molecule
Small molecule
Registry-listed formulations
almotriptan · mesh:C409045
Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.
1 source entries across 1 studies. This list may not include all unresolved or historical entries.
- Almotriptan 12.5 Mg Oral TabletRegistry intervention
Linked study entry; product equivalence not established
View study and source
Success Metrics
Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(50%)
Phase Distribution
Phase 4
2
100%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution2 total trials
Phase 4Post-market surveillance
2(100.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
2
all time
Status Distribution
Terminated(1)
Other(1)
Detailed Status
Terminated1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
2
Active
0
Success Rate
N/A
Most Advanced
Phase 4
Trials by Phase
Phase 42 (100.0%)
Trials by Status
terminated150%
unknown150%
Recent Activity
Clinical Trials (2)
Drug Details
- Intervention Type
- Drug
- Molecule Type
- Small molecule
- Total Trials
- 2
External References
ChEMBL
CHEMBL1505